30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q13 Revenue: Symmetry Medical

$98.9MM, -2%

  • Instruments $28.2MM, +4%
  • Implants $26.0MM, +5%
  • Cases $16.4MM, +3%
  • Surgical $22.2MM, -17%

Noting stable customer spending on instruments, cases and improved demand for implants from OEMs

Surgical decrease attributed to sales disruptions with certain U.S. customers, transition to distributorships in rest of world related to integration of Codman business